Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-052384
Filing Date
2018-09-26
Accepted
2018-09-26 20:47:14
Documents
1
Period of Report
2018-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11118
  Complete submission text file 0001209191-18-052384.txt   12720
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 24 LUCILLE LANE DIX HILLS NY 11746
Business Address
Kalb Michael Wayne (Reporting) CIK: 0001678248 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 181089265